Fundraising FoxFlying L Partners
Private equityLate Stage · 5 people tracked
Find your way into Flying L Partners
Sign up to see every warm intro you have to Flying L Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Flying L Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Flying L Partners is a partnership of experienced colleagues focused on driving innovation in the ophthalmic sector and generating value for investors. Its strategy is opportunity-driven: the firm first identifies a promising company, then raises capital specifically to invest in that opportunity, rather than deploying from a pre-committed blind pool. After investing, the partners engage deeply with the company to accelerate its progress, keeping a tight focus on innovation in eye care and related technologies.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website
What they invest in
from 9 of 11 portfolio companiesHealthtech ×6Biotech ×5Medical Devices ×4Advanced Manufacturing ×1Enterprise Software ×1Hardware ×1
HQs:United States×6Hungary×1
Investments · 11 tracked
founders shown can be your intro pathBy year:2022 · 12019 · 23 dated
RxSight is an ophthalmic medical technology company that developed the Light Adjustable Lens (LAL), an intraocular lens that can be customized after cataract surgery to optimize a patient's vision.
HardwareHealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRon Kurtz(Chief Medical Officer (former President & CEO))Mark Wilterding(Chief Financial Officer)in
Co-investorsForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA CapitalVisionary Ventures+2 more
Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.
BiotechHealthtechMedical Devices
Bobak Azamian(Founder)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)Aziz Mottiwala(Chief Commercial Officer)inDianne Whitfield(Chief Human Resources Officer)inElizabeth Yeu-Lin(Chief Medical Officer)
Co-investorsAPERTURE Venture PartnersFrazier Life SciencesVisionary VenturesVivo CapitalBain Capital Life SciencesRTW Investments L.P.
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)
BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)William J. Link(Director)
Co-investorsEvidity Health CapitalRevelation PartnersWestern Technology InvestmentHEALTHCARE ROYALTY PARTNERSSV Life SciencesVersant Venture AIV Holdings+1 more
Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.
BiotechHealthtechMedical DevicesSeattle, US
DAVID ROSTOV(Executive Officer)inGREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)
Co-investorsVisionary VenturesDeerfield Management Company
HealthtechSioux Falls, US
TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)
BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)
Co-investorsVersant Venture AIV Holdings
Falcon Vision is a Hungarian company active in industrial digitalization and lean management, associated with the Magyar DigiLean Egyesület (Hungarian DigiLean Association) and its industrial exhibition activities.
Advanced ManufacturingEnterprise Software
Co-investorsV4C Advisers Sp. Z.o.o.
Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain.
HealthtechMedical Devices
Co-investorsTrinity Capital
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardWilliam J Link(Director)Ali Behbahani(Director)in
Co-investorsNew Enterprise Associates (NEA)Versant Venture AIV HoldingsVersant VenturesVida Ventures
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)in
BoardWilliam Link(Director)Jeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Co-investorsVisionary VenturesVersant Venture AIV Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CorneagenSurface Pharmaceuticals, Inc.
Exits · 2
2 IPOsRxsightNASDAQ: RXSTTarsus PharmaceuticalsNASDAQ: TARS
Frequently asked questions
- How many investments has Flying L Partners made?
- Flying L Partners has 11 tracked investments, 2 of which have exited.
- What stage does Flying L Partners invest at?
- Flying L Partners invests at the Late Stage stage.
- What sectors does Flying L Partners focus on?
- Flying L Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Who does Flying L Partners co-invest with?
- Flying L Partners most often shares deals with Visionary Ventures, Foresite Capital, Longitude Capital, among 12 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.